Effective blood pressure treatment improves LDL‐cholesterol susceptibility to oxidation in patients with essential hypertension

Abstract. Quiñones‐Galvan A, Pucciarelli A, Fratta‐Pasini A, Garbin U, Franzoni F, Galetta F, Natali A, Cominacini L, Ferrannini E (University of Pisa; and Istituto di Semeiotica Medica, University of Verona, Italy). Effective blood pressure treatment improves LDL‐cholestrol susceptibility to oxidation in patients with essential hypertension. J Intern Med 2001; 250: 322–326.

[1]  G. Bellomo,et al.  Low-density lipoprotein oxidation in essential hypertension , 1993, Journal of hypertension.

[2]  T. Watanabe,et al.  Effects of pressor substances on low density lipoprotein peroxidation by Cu++. , 1997, Journal of atherosclerosis and thrombosis.

[3]  C. Shapira,et al.  Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. , 1994, Atherosclerosis.

[4]  D. Harrison,et al.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.

[5]  L. Hansson.  The Hypertension Optimal Treatment study and the importance of lowering blood pressure. , 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[6]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[7]  G. Born.  From atherosclerosis to thrombosis , 1992 .

[8]  M. Niwa,et al.  Nicardipine normalizes elevated levels of antioxidant activity in response to xanthine oxidase-induced oxidative stress in hypertensive rat heart. , 1998, Free radical research.

[9]  K. Hirata,et al.  Stretch force on vascular smooth muscle cells enhances oxidation of LDL via superoxide production. , 1998, The American journal of physiology.

[10]  E. Ferrannini,et al.  Evidence that acute insulin administration enhances LDL cholesterol susceptibility to oxidation in healthy humans. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[11]  G. Gaviraghi,et al.  A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. , 1991, Journal of lipid research.

[12]  N. Ma,et al.  Effect of gamma-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR). , 1999 .

[13]  R. Coleman,et al.  The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice. , 1999, Cardiovascular research.

[14]  T. Ishikawa,et al.  Effects of Ca-antagonists on oxidative susceptibility of low density lipoprotein (LDL). , 1995, Hypertension research : official journal of the Japanese Society of Hypertension.

[15]  M. Newaz,et al.  Effect of gamma-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR). , 1999, Clinical and experimental hypertension.